Literature DB >> 15463990

A restricted maximum likelihood estimator for truncated height samples.

Brian A'Hearn1.   

Abstract

A restricted maximum likelihood (ML) estimator is presented and evaluated for use with truncated height samples. In the common situation of a small sample truncated at a point not far below the mean, the ordinary ML estimator suffers from high sampling variability. The restricted estimator imposes an a priori value on the standard deviation and freely estimates the mean, exploiting the known empirical stability of the former to obtain less variable estimates of the latter. Simulation results validate the conjecture that restricted ML behaves like restricted ordinary least squares (OLS), whose properties are well established on theoretical grounds. Both estimators display smaller sampling variability when constrained, whether the restrictions are correct or not. The bias induced by incorrect restrictions sets up a decision problem involving a bias-precision tradeoff, which can be evaluated using the mean squared error (MSE) criterion. Simulated MSEs suggest that restricted ML estimation offers important advantages when samples are small and truncation points are high, so long as the true standard deviation is within roughly 0.5 cm of the chosen value.

Entities:  

Mesh:

Year:  2004        PMID: 15463990     DOI: 10.1016/j.ehb.2003.12.003

Source DB:  PubMed          Journal:  Econ Hum Biol        ISSN: 1570-677X            Impact factor:   2.184


  3 in total

1.  Height and the normal distribution: evidence from Italian military data.

Authors:  Brian A'Hearn; Franco Peracchi; Giovanni Vecchi
Journal:  Demography       Date:  2009-02

2.  Estimating age of mature adults from the degeneration of the sternal end of the clavicle.

Authors:  Ceri G Falys; Dennis Prangle
Journal:  Am J Phys Anthropol       Date:  2014-10-18       Impact factor: 2.868

3.  A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.

Authors:  S Cascinu; R Berardi; S Salvagni; G D Beretta; V Catalano; F Pucci; A Sobrero; P Tagliaferri; R Labianca; M Scartozzi; F Crocicchio; E Mari; A Ardizzoni
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.